DelveInsight launched a new report on Down Syndrome (DS) Market Insights, Epidemiology, and Market Forecast 2030.
Down Syndrome (DS) is a genetic disorder caused by the presence of an extra copy of chromosome 21 making a total of 47 chromosomes instead of 46. The condition is associated with intellectual disability, a characteristic facial appearance, and weak muscle tone (hypotonia) in infancy.
DelveInsight’s “Down Syndrome (DS) Market Report 2030” delivers an in-depth understanding of the historical and forecasted epidemiology and the market trends of Down syndrome (DS) in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The total diagnosed prevalent population of Down syndrome (DS) in 7MM countries was estimated to be 699,750 cases in 2017.
Down Syndrome Key Pharma Players Involved:
Request for a free sample pages for the report: https://www.delveinsight.com/sample-request/down-syndrome-market
“The market size of Down syndrome in the seven major markets was found to be USD 662.9 million in 2017.”
Click here and get access to free sample pages of the report.
Table of contents:1 Key Insight2 Executive Summary of Down Syndrome3 Down Syndrome Market Overview at a Glance4 Disease Background and Overview: Down Syndrome5 Case Reports6 Down Syndrome Epidemiology and Patient Population7 United States Epidemiology8 EU5 Epidemiology9 Japan Epidemiology10 Current Down Syndrome Treatment and Medical Practices11 Unmet needs12 Down Syndrome Marketed Drugs13 Down Syndrome Emerging Drugs14 Down Syndrome 7MM Market Analysis15 United States16 EU-5 countries: Market Outlook17 Japan Market Outlook18 Down Syndrome Market Drivers19 Down Syndrome Market Barriers20 SWOT Analysis21 Reimbursement and market access22 Appendix23 DelveInsight Capabilities24 Disclaimer25 About DelveInsight
Download our full report @https://www.delveinsight.com/sample-request/down-syndrome-market
About DelveInsightDelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kritika RehaniEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/